CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market to grow by USD 2.23 billion between 2023 and 2028, growth Driven by High target affinity and specificity of CTLA4 inhibitors – Technavio

The expansion of research indications of CTLA4 is a major trend in the market NEW YORK, Jan. 25, 2024 /PRNewswire/ — The CTLA4 (cytotoxic t-lymphocyte-associated protein 4) inhibitors market is estimated to grow by USD 2.23 billion from 2023 to 2028, growing at a CAGR of 15.11%. High…